Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1 1

Status

Unknown 3Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Breast Neoplasms 7244Neoplasms 4539Prostatic Neoplasms 3489Colorectal Neoplasms 2940Carcinoma, Non-Small-Cell Lung 2831Lung Neoplasms 2547Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1874Multiple Myeloma 1811Carcinoma, Hepatocellular 1733Neoplasm Metastasis 1585Stomach Neoplasms 1502Lymphoma 1457Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1435Brain Neoplasms 1373Melanoma 1348Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1138Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Disease Attributes × Clear all
NCT03464305 2024-03-19

ASPIRIN

University Hospital, Antwerp

Phase 3 Active not recruiting
148 enrolled
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Pathologic Processes, Recurrence, Colorectal Neoplasms, Disease Attributes

NCT04831307 2021-12-03

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

British Columbia Cancer Agency

Phase NA Unknown
10 enrolled
Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Disease Attributes

NCT04462926 2020-09-17

PSMA-PROSTAPET

Azienda Ospedaliero-Universitaria di Modena

Phase NA Unknown
100 enrolled
Genitourinary

Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Disease Attributes

NCT03114670 2017-06-14

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Affiliated Hospital to Academy of Military Medical Sciences

Phase 1 Unknown
20 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms by Histologic Type, Recurrence, Leukemia, Myeloid, Acute, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡